Overview

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Status:
Terminated

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and tolerability of dutogliptin in Type 2 diabetic subjects with moderate or severe renal impairment.

Phase:

Phase 3

Details

Lead Sponsor:

Phenomix

Collaborator:

Forest Laboratories

Treatments:

Sitagliptin Phosphate